Thus, taken together, these findings argue for the use of physical exercise as a therapeutic intervention for SMA patients, in complement to pharmacological or gene-therapies aimed at improving SMN expression in MNs. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.